Atlanta, GA4 Active Studies

Hemophilia Clinical Trials in Atlanta, GA

Find 4 actively recruiting hemophilia clinical trials in Atlanta, GA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
200
Enrolling

Recruiting Hemophilia Studies in Atlanta

NCT04023019Recruiting

Treatment of Hemophilia A Patients With FVIII Inhibitors

This is a non-interventional, multicenter, observational, international study in male persons with haemophilia A who have developed inhibitors to any replacement coagulation factor VIII (FVIII) produc...

Atlanta, GA120 participantsEmory University
View Study Details
NCT04647227Recruiting

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are either on long term prophylactic treatment...

Atlanta, GAPHASE455 participantsAmerican Thrombosis and Hemostasis Network
View Study Details
NCT07080905Recruiting

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

This is a phase 3, prospective, open-label, single-arm, single-dose, multicenter study investigating the efficacy, safety, and tolerability of CSL222 (AAV5-hFIXco-Padua) in adolescent male participant...

Atlanta, GAPHASE320 participantsCSL Behring
View Study Details
NCT04563520Recruiting

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

The purpose of the aPCC-emicizumab safety study is to investigate the hemostatic efficacy as measured by thrombin generation, of a low personalized dose of aPCC (FEIBA) in children and adults with hem...

Atlanta, GAPHASE35 participantsEmory University
View Study Details

About Hemophilia Clinical Trials in Atlanta

Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.

There are currently 4 hemophilia clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 200 participants. Research is being sponsored by Emory University, American Thrombosis and Hemostasis Network, CSL Behring. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hemophilia Clinical Trials in Atlanta — FAQ

Are there hemophilia clinical trials in Atlanta?

Yes, there are 4 hemophilia clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What hemophilia treatments are being tested?

The 4 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.

Data updated October 14, 2026 from ClinicalTrials.gov